Skip to content
Therapy But Better – Lifestyle
Author:
JenaValve Technology, Inc.
JenaValve Presents Late-Breaking JENA-VAD Data at TCT 2026, Demonstrating High Technical Success and 30 Day Safety of the Trilogy System in LVAD Patients Under IDE
November 10, 2026
JenaValve Recaps Key Highlights Including Late-Breaking Clinical Data from New York Valves 2026
July 1, 2026
JenaValve Appoints Matt Bacso as Chief Financial Officer
June 10, 2026
JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance
June 3, 2026
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
May 27, 2026
JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
May 20, 2026